Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank91
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P91
Near historical high
vs 2Y Ago
2.5x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q3 202535.29%
Q2 2025-41.67%
Q1 202522.58%
Q4 2024-24.00%
Q3 2024-47.06%
Q2 2024-36.00%
Q1 202410.71%
Q4 2023-16.67%
Q3 202314.29%
Q2 2023-21.74%
Q1 202332.35%
Q4 2022-36.00%
Q3 2022-4.17%
Q2 2022-9.09%
Q1 20220.00%
Q4 2021-120.00%
Q3 202193.71%
Q2 2021-117.81%
Q1 2021-2665.15%
Q4 202069.62%
Q3 2020-22.39%
Q2 20200.56%
Q1 20200.00%